Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin structure.

B Casu1

  • 1Istituto di Chimica e Biochimica G. Ronzoni, Milano, Italia.

Haemostasis
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Heparin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparins.

International journal of clinical pharmacology and therapeutics·2010
Same author

Recommendations on biosimilar low-molecular-weight heparins.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Endometriosis of the round ligament: description of a clinical case and review of the literature.

Hernia : the journal of hernias and abdominal wall surgery·2005
Same author

Involvement of heparanase in tumor progression and normal differentiation.

Pathophysiology of haemostasis and thrombosis·2003
Same author

[Left pyo-pneumothorax: a rare complication of colon carcinoma].

Tumori·2003
Same author

Structure and biological interactions of heparin and heparan sulfate.

Advances in carbohydrate chemistry and biochemistry·2002

Area of Science:

  • Biochemistry
  • Glycoscience
  • Pharmacology

Background:

  • Therapeutic heparins are complex glycosaminoglycans.
  • Heparin structure consists of repeating disaccharide units.
  • Specific sequences within heparin dictate its biological activity.

Purpose of the Study:

  • To elucidate the structural basis of heparin's diverse biological functions.
  • To identify specific sequences responsible for binding heparin cofactors and plasma proteins.
  • To understand the role of structural variations in heparin's therapeutic efficacy.

Main Methods:

  • Analysis of heparin's complex polysaccharide structure.
  • Identification of specific sequence motifs within heparin.
  • Correlation of structural features with protein binding properties.

Related Experiment Videos

Main Results:

  • Heparin's structure is characterized by regular trisulfated disaccharide sequences and variable undersulfated sequences.
  • A specific pentasaccharide sequence containing 3-O-sulfated D-glucosamine is the active site for antithrombin.
  • Heparin cofactor-II binds primarily to the regular, highly sulfated sequences.
  • Conformational flexibility of iduronic acid residues enhances binding versatility.

Conclusions:

  • Heparin's biological activity is sequence-dependent.
  • Structural heterogeneity of heparin contributes to its diverse interactions with proteins.
  • Understanding heparin structure-activity relationships is crucial for developing targeted therapies.